Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AstraZeneca’s Tagrisso meets secondary endpoint in phase III lung cancer study
Image: AstraZeneca’s Tagrisso has achieved in secondary endpoint in phase III lung cancer study. Photo: courtesy of AstraZeneca.
Image: AstraZeneca’s Tagrisso has achieved in secondary endpoint in phase III lung cancer study. Photo: courtesy of AstraZeneca.